Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy

Djamel Lebeche1, Amy J Davidoff, Roger J Hajjar

  • 1Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY 10029, USA. djamel.lebeche@mssm.edu

Insights

Diabetic cardiomyopathy impairs heart function in diabetes patients, independent of other risk factors. Understanding cellular changes in cardiomyocytes is key to predicting cardiac consequences.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetes mellitus affects 380 million people globally, with cardiovascular disease as a leading cause of mortality.
  • Diabetic cardiomyopathy, a distinct myocardial condition, contributes to heart failure in diabetic patients.
  • This condition presents with ventricular dysfunction, irrespective of hypertension or coronary artery disease.

Purpose of the Study:

  • To elucidate the cellular and molecular mechanisms underlying diabetic cardiomyopathy.
  • To explore the link between calcium homeostasis, insulin signaling, and cardiac dysfunction in diabetes.
  • To provide insights into predicting cardiac structural and functional changes in diabetic patients.

Main Methods:

  • Review of existing literature on diabetic cardiomyopathy.
  • Analysis of cellular and molecular pathways involved in cardiac dysfunction.
  • Examination of the role of calcium homeostasis and insulin signaling.

Main Results:

  • Diabetic cardiomyopathy is characterized by early diastolic and late systolic dysfunction.
  • Key pathological mechanisms include disrupted calcium regulation, abnormal excitation-contraction coupling, metabolic disturbances, and altered insulin signaling.
  • Emerging evidence suggests a connection between impaired calcium homeostasis and reduced insulin responsiveness.

Conclusions:

  • Diabetic cardiomyopathy is a complex, multifactorial condition impacting cardiac function.
  • Understanding cellular perturbations in cardiomyocytes is crucial for predicting diabetic heart disease.
  • Targeting calcium homeostasis and insulin signaling pathways may offer therapeutic strategies.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...